Kreftforeningen finansierer en tredjedel av kreftforskningen i Norge. Årlig fordeles mer enn 200 millioner kroner gjennom Open Call, men relativt få prosjekt ender opp i Midt-Norge. Hva er årsaken til dette, og hvordan skal vi jobbe for å synliggjøre, og lykkes med finansiering av den gode kreftforskningen som gjøres i miljøene i Midt-Norge?
PROVIZ, an MR imaging and analysis team based at NTNU, has continued their journey from excellent science to real-world cancer diagnosis, earning two new innovation awards. They have renewed their partnership with Digital Life Norway’s Innovation Roadmap project with a 1.5M NOK pilot project to build their regulatory and clinical roadmap, and have also won the NTNU Discovery main project award worth 1 million NOK to support technical and product development.
Centre for Digital Life Norway is a national centre for biotechnology research and innovation and is funded by the Research Council of Norway.
